D
Danièle Maubon
Researcher at University of Grenoble
Publications - 65
Citations - 1678
Danièle Maubon is an academic researcher from University of Grenoble. The author has contributed to research in topics: Candida albicans & Medicine. The author has an hindex of 19, co-authored 61 publications receiving 1316 citations. Previous affiliations of Danièle Maubon include Joseph Fourier University & French Institute of Health and Medical Research.
Papers
More filters
Journal ArticleDOI
Pneumocystis jirovecii pneumonia in patients with or without AIDS, France.
Antoine Roux,Emmanuel Canet,Sandrine Valade,Florence Gangneux-Robert,Samia Hamane,Ariane Lafabrie,Danièle Maubon,Anne Debourgogne,Solène Le Gal,Frédéric Dalle,M. Leterrier,Dominique Toubas,Christelle Pomares,Anne-Pauline Bellanger,Julie Bonhomme,Antoine Berry,Isabelle Durand-Joly,Denis Magne,Denis Pons,Christophe Hennequin,Eric Maury,Patricia Roux,Elie Azoulay +22 more
TL;DR: Immunosuppressed patients without AIDS had longer time to treatment and a higher rate of death than did patients with AIDS.
Journal ArticleDOI
Drug inhibition of HDAC3 and epigenetic control of differentiation in Apicomplexa parasites
Alexandre Bougdour,Danièle Maubon,Patricia Baldacci,Philippe Ortet,Olivier Bastien,Anthony Bouillon,Jean-Christophe Barale,Hervé Pelloux,Robert Ménard,Mohamed-Ali Hakimi +9 more
TL;DR: The results identify FR235222 as a potent HDACi of Apicomplexa, and establish HDAC3 as a central regulator of gene expression and stage conversion in Toxoplasma and, likely, other ApicOMplexa.
Journal ArticleDOI
Empirical Micafungin Treatment and Survival Without Invasive Fungal Infection in Adults With ICU-Acquired Sepsis, Candida Colonization, and Multiple Organ Failure: The EMPIRICUS Randomized Clinical Trial
Jean-François Timsit,Jean-François Timsit,Elie Azoulay,Carole Schwebel,Pierre Emmanuel Charles,Muriel Cornet,Bertrand Souweine,Kada Klouche,Samir Jaber,Jean-Louis Trouillet,Fabrice Bruneel,Laurent Argaud,Joel Cousson,Ferhat Meziani,Didier Gruson,Adeline Paris,Michael Darmon,Maité Garrouste-Orgeas,Jean-Christophe Navellou,Arnaud Foucrier,Bernard Allaouchiche,Vincent Das,Jean-Pierre Gangneux,Stéphane Ruckly,Danièle Maubon,Vincent Jullien,Michel Wolff,Michel Wolff +27 more
TL;DR: Among nonneutropenic critically ill patients with ICU-acquired sepsis, Candida species colonization at multiple sites, and multiple organ failure, empirical treatment with micafungin, compared with placebo, did not increase fungal infection-free survival at day 28.
Journal ArticleDOI
Resistance of Candida spp. to antifungal drugs in the ICU: where are we now?
TL;DR: An overview of the mechanisms of action of the drugs and of resistance in pathogenic yeasts and the emergence of clinical treatment failures due to resistant isolates is described, taking into account the growing threat of antifungal drug resistance.
Journal ArticleDOI
Antifungal use influences Candida species distribution and susceptibility in the intensive care unit
Pierre Fournier,Carole Schwebel,Danièle Maubon,Aurélien Vesin,B. Lebeau,Luc A. Foroni,Rebecca Hamidfar-Roy,Muriel Cornet,Jean-François Timsit,Hervé Pelloux +9 more
TL;DR: Antifungal drug use in the ICU is associated with major changes in the distribution and drug susceptibility of Candida spp.